Apotex to restart oral solid dose products shipping to US
The decision to restart the oral solid dose products to US was based on the US Food and Drug Administration’s (FDA) decision to lift its import alert at
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.